Daniele Dionisio

Summary

Country: Italy

Publications

  1. ncbi Impending flop for brand antiretrovirals in the emerging markets?
    Dionisio Daniele
    Access to Drugs International Policies Italian Network for International Fight against AIDS, Italian Society for Infectious and Tropical Diseases, Division of Infectious Diseases, Pistoia Hospital, Pistoia, Italy
    Open AIDS J 2:68-71. 2008
  2. ncbi Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Daniele Dionisio
    Infectious Disease Division, Pistoia Hospital, 51100 Pistoia, Italy
    Curr HIV Res 4:3-20. 2006
  3. ncbi What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Daniele Dionisio
    Infectious Disease Division, Pistoia Hospital, Pistoia, Italy
    Curr HIV Res 5:155-87. 2007
  4. ncbi Priority strategies for sustainable fight against HIV/AIDS in low-income countries
    Daniele Dionisio
    Infectious Diseases Unit, Pistoia Hospital, Pistoia, Italy
    Curr HIV Res 2:377-93. 2004
  5. ncbi Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics
    Daniele Dionisio
    Access to Drugs International Policies CLIA Italian Network for International Fight against AIDS, Italian Society for Infectious and Tropical Diseases SIMIT, Division of Infectious Diseases, Pistoia Hospital, Pistoia, Italy
    Open AIDS J 4:70-5. 2010
  6. ncbi Antiretroviral treatment in resource-poor settings: a challenging task for broad-based multi-sectorial responses
    Daniele Dionisio
    Indian J Med Sci 61:377-8. 2007

Collaborators

Detail Information

Publications6

  1. ncbi Impending flop for brand antiretrovirals in the emerging markets?
    Dionisio Daniele
    Access to Drugs International Policies Italian Network for International Fight against AIDS, Italian Society for Infectious and Tropical Diseases, Division of Infectious Diseases, Pistoia Hospital, Pistoia, Italy
    Open AIDS J 2:68-71. 2008
    ..To secure all formulations differentiated prices.To align with the Clinton-UNITAID prices for the corresponding generics.To pursue flexible negotiations with the generic companies to secure both counterparts long-term advantages...
  2. ncbi Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Daniele Dionisio
    Infectious Disease Division, Pistoia Hospital, 51100 Pistoia, Italy
    Curr HIV Res 4:3-20. 2006
    ....
  3. ncbi What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Daniele Dionisio
    Infectious Disease Division, Pistoia Hospital, Pistoia, Italy
    Curr HIV Res 5:155-87. 2007
    ..Children presently account for about 4% of all treated patients, while for equitable access they should make up at least 13%...
  4. ncbi Priority strategies for sustainable fight against HIV/AIDS in low-income countries
    Daniele Dionisio
    Infectious Diseases Unit, Pistoia Hospital, Pistoia, Italy
    Curr HIV Res 2:377-93. 2004
    ....
  5. ncbi Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics
    Daniele Dionisio
    Access to Drugs International Policies CLIA Italian Network for International Fight against AIDS, Italian Society for Infectious and Tropical Diseases SIMIT, Division of Infectious Diseases, Pistoia Hospital, Pistoia, Italy
    Open AIDS J 4:70-5. 2010
    ....
  6. ncbi Antiretroviral treatment in resource-poor settings: a challenging task for broad-based multi-sectorial responses
    Daniele Dionisio
    Indian J Med Sci 61:377-8. 2007